"Designing Growth Strategies is in our DNA"

Mexico Hemostats Market Size, Share & COVID-19 Impact Analysis, By Product (Active {Thrombin based, and Fibrin Sealants}, Passive {Plant Based, Animal-Based, and Others}, Combination Hemostats, and Others); By Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, and Others); By End-User (Hospitals & ASCs, Tactical Combat Casualty Care Centers, and Others), and Forecast, 2021-2028

Last Updated: February 10, 2025 | Format: PDF | Report ID: FBI106189

 


To get information on various segments, share your queries with us

  ATTRIBUTE

  DETAILS

Study Period

2017-2028

Base Year

2020

Estimated Year

 2021

Forecast Period

2021-2028

Historical Period

2017-2019

Unit

Value (USD million)

Segmentation

By Product

  • Active
    • Thrombin based
    • Fibrin Sealants
  • Passive
    • Plant-Based
    • Animal Based
    • Others
  • Combination Hemostats
  • Others

By Application

  • Trauma
  • Cardiovascular Surgery
  • General Surgery
  • Plastic Surgery
  • Orthopedic Surgery
  • Neurosurgery
  • Others

By End-User

  • Hospitals & ASCs
  • Tactical Combat Casualty Care Centers
  • Others
  • 2017-2028
  • 2020
  • 2017-2019
  • 91
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann